These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 21220758)
21. Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease. Atamer A; Kocyigit Y; Ecder SA; Selek S; Ilhan N; Ecder T; Atamer Y J Nephrol; 2008; 21(6):924-30. PubMed ID: 19034878 [TBL] [Abstract][Full Text] [Related]
22. Effect of gemfibrozil on change in renal function in men with moderate chronic renal insufficiency and coronary disease. Tonelli M; Collins D; Robins S; Bloomfield H; Curhan GC Am J Kidney Dis; 2004 Nov; 44(5):832-9. PubMed ID: 15492949 [TBL] [Abstract][Full Text] [Related]
23. Hyperlipidemia in children with chronic renal insufficiency. Papadopoulou ZL; Sandler P; Tina LU; Jose PA; Calcagno PL Pediatr Res; 1981 Jun; 15(6):887-91. PubMed ID: 7243391 [TBL] [Abstract][Full Text] [Related]
24. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Samuelsson O; Mulec H; Knight-Gibson C; Attman PO; Kron B; Larsson R; Weiss L; Wedel H; Alaupovic P Nephrol Dial Transplant; 1997 Sep; 12(9):1908-15. PubMed ID: 9306342 [TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency. Samuelsson O; Aurell M; Knight-Gibson C; Alaupovic P; Attman PO Nephron; 1993; 63(3):279-85. PubMed ID: 8446264 [TBL] [Abstract][Full Text] [Related]
26. Lipoprotein abnormalities as a risk factor for progressive nondiabetic renal disease. Attman PO; Alaupovic P; Samuelsson O Kidney Int Suppl; 1999 Jul; 71():S14-7. PubMed ID: 10412728 [TBL] [Abstract][Full Text] [Related]
27. Diagnosis and classification of dyslipidemia in renal disease. Attman PO; Samuelsson O; Alaupovic P Blood Purif; 1996; 14(1):49-57. PubMed ID: 8718566 [TBL] [Abstract][Full Text] [Related]
31. Relation of atherogenic lipoproteins with estimated glomerular filtration rate decline: a longitudinal study. Lin J; Khetarpal SA; Terembula K; Reilly MP; Wilson FP BMC Nephrol; 2015 Aug; 16():130. PubMed ID: 26238454 [TBL] [Abstract][Full Text] [Related]
32. LpA-II:B:C:D:E: a new immunochemically-defined acute phase lipoprotein in humans. Bagdade JD; Jilma B; Hudgins LC; Alaupovic P; McCurdy CE Lipids Health Dis; 2018 May; 17(1):127. PubMed ID: 29807532 [TBL] [Abstract][Full Text] [Related]
33. Quartet of APOCs and the Different Roles They Play in Diabetes. Hsu CC; Kanter JE; Kothari V; Bornfeldt KE Arterioscler Thromb Vasc Biol; 2023 Jul; 43(7):1124-1133. PubMed ID: 37226733 [TBL] [Abstract][Full Text] [Related]
34. Emerging Targets for Cardiovascular Disease Prevention in Diabetes. Stitziel NO; Kanter JE; Bornfeldt KE Trends Mol Med; 2020 Aug; 26(8):744-757. PubMed ID: 32423639 [TBL] [Abstract][Full Text] [Related]